Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new…
2015/11/25 – Quantum Genomics’ Scientific Advisory Board recommends next multicentric clinical trials in Europe and United States
Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new…
2015/10/15 – 2015 Half-year results – Update on latest developments
Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new…
2015/10/06 – Positive opinion from Monitoring Board to continue protocol as planned, for Phase IIa clinical trial under way for high blood pressure
Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new…
2015/09/22 – Quantum Genomics to meet investors at the European Large & Midcap Event, October 7 & 8, 2015
Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new…
2015/09/08 – Phase IIa clinical trial for high blood pressure : 50% enrolment four months ahead of schedule and Supervisory Board meeting coming up
Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new…
2015/08/24 – Disclosure of the total number of voting rights and the number of shares of the share capital
Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new…
2015/07/27 – Quantum Genomics announces the appointment of Professor Faiez Zannad as its heart failure consultant
Quantum Genomics (Alternext – FR0011648971 – ALQGC), ), a biopharmaceutical company with the mission of developing new…
2015/07/02 – Quantum Genomics speeds its development work in the field of heart failure
Quantum Genomics (Alternext – FR0011648971 – ALQGC), ), a biopharmaceutical company with the mission of developing…
2015/06/29 – Quantum Genomics obtains positive results with heart failure study in dogs
Quantum Genomics (Alternext – FR0011648971 – ALQGC), ), a biopharmaceutical company with the mission of developing…